Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
J Genet Couns. 2023 Feb;32(1):31-42. doi: 10.1002/jgc4.1618. Epub 2022 Jul 25.
Despite reporting an overall normal life, survivors of heritable retinoblastoma face numerous physical and psychosocial issues. In particular, reproductive decision-making is often complex and difficult. This study aims to examine survivors' reflections on passing on heritable retinoblastoma to their children, how survivors approach their reproductive choices, and how the healthcare system can optimize counseling and support. Semi-structured interviews with Danish adult survivors of heritable retinoblastoma were qualitatively analyzed to explore their experiences. Participants were recruited from the Retinoblastoma Survivorship Clinic, Aarhus University Hospital, Denmark. Thematic data analysis was conducted followed by a condensing process specifically for the subthemes relating to reproductive choices. A common subtheme for all participants was a strong wish to avoid passing on retinoblastoma to their children. The participants emphasized the various medical, practical, emotional, and moral issues impacting their final reproductive choice in the process of family planning to conceive a child unaffected by retinoblastoma. Some had no option other than to conceive naturally and hope for an unaffected baby; while others weighed the pros and cons of choosing natural conception with prenatal testing and then considering termination of pregnancy (in case of an affected fetus) versus choosing fertility treatment with preimplantation genetic testing to achieve an unaffected pregnancy. Several participants underlined the complexity of their decisions, and also expressed feelings of guilt, both toward their affected child, and guilt for putting their partner through many difficult decisions and obstacles due to their genetic condition. Our findings demonstrate how one family-planning decision is not unequivocally "better" or easier than another. Healthcare professionals must provide the necessary information and tools to support the individual's unique decision-making process. Survivors' autonomy and individual needs, as well as the numerous and diverse aspects of heritable retinoblastoma, should be carefully considered.
尽管遗传性视网膜母细胞瘤幸存者报告总体生活正常,但他们仍面临许多身体和心理社会问题。特别是,生殖决策往往复杂且困难。本研究旨在探讨幸存者对将遗传性视网膜母细胞瘤遗传给子女的思考,幸存者如何处理他们的生殖选择,以及医疗保健系统如何优化咨询和支持。对丹麦遗传性视网膜母细胞瘤成年幸存者进行了半结构化访谈,以探索他们的经验。参与者从丹麦奥胡斯大学医院的视网膜母细胞瘤生存者诊所招募。对主题数据进行了分析,然后对与生殖选择相关的亚主题进行了浓缩处理。所有参与者的一个共同亚主题是强烈希望避免将视网膜母细胞瘤遗传给子女。在计划生育以孕育一个不受视网膜母细胞瘤影响的孩子的过程中,参与者强调了影响他们最终生殖选择的各种医疗、实际、情感和道德问题。有些人别无选择,只能自然受孕并希望生下一个不受影响的婴儿;而其他人则权衡了自然受孕与产前检查的利弊,然后考虑终止妊娠(如果胎儿受影响)与选择生育治疗和植入前基因检测以实现不受影响的怀孕。一些参与者强调了他们决策的复杂性,还表达了对受影响孩子的内疚感,以及因遗传状况而使伴侣经历许多艰难决定和障碍的内疚感。我们的研究结果表明,一个计划生育决策并不比另一个更“好”或更容易。医疗保健专业人员必须提供必要的信息和工具,以支持个人独特的决策过程。幸存者的自主权和个人需求,以及遗传性视网膜母细胞瘤的众多和多样化方面,都应仔细考虑。